PHARMASSET INC Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Deprecated 2012-01-31)
PHARMASSET INC reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Deprecated 2012-01-31) of 6.01 years for the 12-month period ending 2011-09-30, per its 10-K filed 2011-11-14.
Discontinued › Notes › Compensation Related Costs
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm · last filed 2011-11-14
- PHARMASSET INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected term (deprecated 2012-01-31) for fiscal 2011 was 6.01 years, a 0.17% increase from fiscal 2010.
- PHARMASSET INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected term (deprecated 2012-01-31) for fiscal 2010 was 6.00 years, a 0.33% increase from fiscal 2009.
- PHARMASSET INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected term (deprecated 2012-01-31) for fiscal 2009 was 5.98 years.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Deprecated 2012-01-31) 12 month |
|---|---|
| 2011-09-30 | 6.01 years 10-K · filed 2011-11-14 |
| 2010-09-30 | 6.00 years 10-K · filed 2011-11-14 |
| 2009-09-30 | 5.98 years 10-K · filed 2011-11-14 |